F₂-isoprostane induced prostaglandin formation in the rabbit

References

• Morrow J, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ, II. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism. Proc Natl Acad Sci USA 1999; 87: 9383–9387
   Google Scholar
• Basu S. Isoprostanes: Novel bioactive compounds of lipid peroxidation. Free Radic Res 2004; 38: 105–122
   PubMed Web of Science ®Google Scholar
• Morrow J, Awad JA, Kato T, Takahashi K, Badr KF, Roberts LJ, II, Burk RF. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. J Clin Investig 1992; 90: 2502–2507
   PubMed Web of Science ®Google Scholar
• Morrow JD, Frei B, Atkinson WL, Giaw JM, Lynch SM, Shyr Y, Strauss WA, Oates JA, Roberts LJ, II. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 1995; 332: 1198–1203
   PubMed Web of Science ®Google Scholar
• Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett, 438: 159–160
   Google Scholar
• Basu S, Nozari A, Liu XL, Rubertsson S, Wiklund L. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett 2000; 470: 1–6
   PubMed Web of Science ®Google Scholar
• Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004; 109: 1729–1734
   PubMed Web of Science ®Google Scholar
• Helmersson J, Larsson A, Vessby B, Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 2005; 181: 201–207
   PubMed Web of Science ®Google Scholar
• Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S, Jynge P, Basu S. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 2004; 38: 517–525
   PubMed Web of Science ®Google Scholar
• Basu S, Smedman A, Vessby B. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett, 468: 33–36
   Google Scholar
• Basu S, Whiteman M, Mattey D, Halliwell B. Elevated levels of F2-isoprostanes and prostaglandin F2α in different rheumatic diseases. Ann Rheum Dis 2001; 60: 627–631
   PubMed Web of Science ®Google Scholar
• Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun 1999; 254: 764–767
   PubMed Web of Science ®Google Scholar
• Ulus AT, Aksovek A, Ozkan M, Katircioglu SF, Basu S. Cardiopulmonary bypass as a cause of free radical induced-oxidative stress and enhanced circulatory isoprostanes in humans. Free Radic Biol Med 2003; 34: 911–917
   PubMed Web of Science ®Google Scholar
• Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ, II, Hoover RL, Badr KFJ. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 in the rat. Clin Invest 1992; 90: 136–141
   Google Scholar
• Basu S. Radioimmunoassay of 8-iso-prostaglandin F2α: An index for oxidative injury via free radical catalysed lipid peroxidation. Prost Leuk Ess Fatty Acids 1998; 58: 319–325
   PubMed Web of Science ®Google Scholar
• Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2α: An index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prost Leuk Ess Fatty Acids 1998; 58: 347–352
   PubMed Web of Science ®Google Scholar
• Samuelsson B, Goldyne M, Granström E, Hamberg M, Hammarström S, Malmsten C. Prostaglandins and thromboxanes. Ann Rev Biochem 1978; 47: 997–1029
   PubMed Web of Science ®Google Scholar
• Samuelsson S. Quantitative aspects of prostaglandin synthesis. Adv Biosci 1973; 9: 7–14
   Google Scholar
• Basu S. Metabolism of 8-iso-prostaglandin F2α. FEBS Lett 1998; 428: 32–36
   PubMed Web of Science ®Google Scholar
• Callewert D, McGowen R, Sloan C, Godshalk K, Solomon T, Basu S, Morrow J, Gupta S. Isoprostane glucoronides in human urine and the evaluation of oxidative stress. Free Radic Biol Med Suppl 2005; 39: 110, Abs. 229
   Google Scholar
• Basu S, Kindahl H. Development of a continuous blood collection technique and a detailed study of prostaglandin F2α. J Vet Med 1987; 34: 487–500
   Google Scholar
• Basu S, Kindahl H, Harvey D, Betteridge KJ. Metabolites of PGF2α in blood plasma and urine as parameter of PGF2α release in cattle. Acta Vet Scand 1987; 28: 409–420
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, Oida H, Yoshida N, Tanaka T, Katsuyama M, Hasumoto K, Murata T, Hirata M, Ushikubi F, Negishi M, Ichikawa A, Narumiya S. Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997; 277: 681–683
   PubMed Web of Science ®Google Scholar
• Patrono C, Dunn MJ. The chemical significance of inhibition of renal prostaglandin synthesis. Kidney Int 1987; 32: 1–12
   PubMed Web of Science ®Google Scholar
• Pavord ID, Tattersfield AE. Broncoprotective role for endogenous prostaglandin E2. Lancet 1995; 344: 436–438
   Google Scholar
• Asmis R, Randrimampita C, Tsien R, Dennis EA. Intracelular Ca2+, inositol-1,4,5-triphosphate and additional signalling in the PAF stimulation of PGE2 formation in P388D1 macrophage-like cells. Biochem J 1984; 298: 543–551
   Google Scholar
• Ishihara O, Hayashi M, Osawa H, Kobayashi K, Takeda S, Vessby B, Basu S. Isoprostanes, prostaglandins and antioxidants in preclampsia, normal pregnancy and non-pregnancy. Free Radic Res 2004; 38: 913–918
   PubMed Web of Science ®Google Scholar